# GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance

> **NCT01381328** · — · UNKNOWN · sponsor: **Università Vita-Salute San Raffaele** · enrollment: 100 (estimated)

## Conditions studied

- HIV-1 Infected Patients
- Fold-change Resistance
- Resistance Mutations

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01381328
- **Lead sponsor:** Università Vita-Salute San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-02-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381328, "GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01381328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*